Literature DB >> 29268496

Tumor microenvironment as a potential source of clinical biomarkers in non-small cell lung cancer: can we use enemy territory at our advantage?

Carlo Genova1,2, Erika Rijavec1, Francesco Grossi1.   

Abstract

Entities:  

Year:  2017        PMID： 29268496      PMCID： PMC5721017          DOI： 10.21037/jtd.2017.10.66

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin.

Authors:  Patrizia Castellani; Laura Borsi; Barbara Carnemolla; Attila Birò; Alessandra Dorcaratto; Giuseppe L Viale; Dario Neri; Luciano Zardi
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.

Authors:  Vasilena Gocheva; Alexandra Naba; Arjun Bhutkar; Talia Guardia; Kathryn M Miller; Carman Man-Chung Li; Talya L Dayton; Francisco J Sanchez-Rivera; Caroline Kim-Kiselak; Noor Jailkhani; Monte M Winslow; Amanda Del Rosario; Richard O Hynes; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

3.  Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.

Authors:  Zhaoting Yang; Weidong Ni; Chunai Cui; Longyun Fang; Yanhua Xuan
Journal:  Exp Mol Pathol       Date:  2017-02-20       Impact factor: 3.362

Review 4.  Understanding the checkpoint blockade in lung cancer immunotherapy.

Authors:  Maria Giovanna Dal Bello; Angela Alama; Simona Coco; Irene Vanni; Francesco Grossi
Journal:  Drug Discov Today       Date:  2017-06-07       Impact factor: 7.851

Review 5.  Remodelling the extracellular matrix in development and disease.

Authors:  Caroline Bonnans; Jonathan Chou; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12       Impact factor: 94.444

6.  Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cells.

Authors:  L Borsi; G Allemanni; B Gaggero; L Zardi
Journal:  Int J Cancer       Date:  1996-05-29       Impact factor: 7.396

Review 7.  The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment.

Authors:  Hannelore Denys; Geert Braems; Kathleen Lambein; Patrick Pauwels; An Hendrix; Astrid De Boeck; Véronique Mathieu; Marc Bracke; Olivier De Wever
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 8.  Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment.

Authors:  Mira Stadler; Stefanie Walter; Angelika Walzl; Nina Kramer; Christine Unger; Martin Scherzer; Daniela Unterleuthner; Markus Hengstschläger; Georg Krupitza; Helmut Dolznig
Journal:  Semin Cancer Biol       Date:  2015-08-28       Impact factor: 15.707

Review 9.  The extracellular matrix: a dynamic niche in cancer progression.

Authors:  Pengfei Lu; Valerie M Weaver; Zena Werb
Journal:  J Cell Biol       Date:  2012-02-20       Impact factor: 10.539

10.  Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.

Authors:  F Grossi; E Rijavec; C Genova; G Barletta; F Biello; C Maggioni; G Burrafato; C Sini; M G Dal Bello; K Meyer; J Roder; H Roder; J Grigorieva
Journal:  Br J Cancer       Date:  2016-11-29       Impact factor: 7.640
View more
  4 in total

1.  A Single-Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer.

Authors:  Xiaofeng Chen; Tianzhu Qiu; Yingwei Zhu; Jing Sun; Ping Li; Biao Wang; Peinan Lin; Xiaomin Cai; Xiao Han; Fengjiao Zhao; Yongqian Shu; Lianpeng Chang; Hua Jiang; Yanhong Gu
Journal:  Oncologist       Date:  2019-03-15

2.  Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies.

Authors:  Sayda Dhaouadi; Rahma Ben Abderrazek; Thomas Loustau; Chérine Abou-Faycal; Ayoub Ksouri; William Erne; Devadarssen Murdamoothoo; Matthias Mörgelin; Andreas Kungl; Alain Jung; Sonia Ledrappier; Zakaria Benlasfar; Sandrine Bichet; Ruth Chiquet-Ehrismann; Ismaïl Hendaoui; Gertraud Orend; Balkiss Bouhaouala-Zahar
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

3.  A Naive Bayes model on lung adenocarcinoma projection based on tumor microenvironment and weighted gene co-expression network analysis.

Authors:  Zhiqiang Ye; Pingping Song; Degao Zheng; Xu Zhang; Jianhong Wu
Journal:  Infect Dis Model       Date:  2022-08-09

4.  Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.

Authors:  Yuan Zhou; Xinying Shi; Huan Chen; Beibei Mao; Xue Song; Lingling Gao; Jiao Zhang; Ying Yang; Henghui Zhang; Guo Wang; Wei Zhuang
Journal:  Biomed Res Int       Date:  2021-07-10       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.